Latest Nutritional Supplements News

Me Today has raised its full-year revenue forecast to over NZD 7.4 million, driven by strong domestic sales and a new exclusive distribution deal in Southeast Asia. The nutritional supplements company also expects a 25% reduction in EBITDA loss, reflecting tighter cost control amid ongoing product innovation.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.

RLF AgTech’s 2025 Oldbury Wheat Trial reveals a substantial profitability uplift with its Complete Crop Nutrition Program, highlighting a significant opportunity in Australia’s broadacre wheat sector.

Nuchev Limited reported a 19% decline in Q2 FY26 sales revenue, with steady retail performance in its Oli6® brand offset by a sharp drop in the Practitioner channel. The company remains debt-free and is advancing new product development to drive future growth.

Nutritional Growth Solutions announces the departure of CEO Stephen J. Turner, appointing Non-Executive Director Andrew Grover as interim CEO to steer the company through its next phase.

Vita Life Sciences forecasts solid sales and profit growth for FY2025, driven by strong performances in Malaysia and Singapore, while cautiously managing challenges in China exports.

Jatcorp Limited has announced a fully underwritten pro-rata rights issue to raise approximately $4.2 million, aiming to strengthen working capital and accelerate growth in China and Southeast Asia. Eligible shareholders can subscribe at $0.15 per share with an option for additional shares under a Top-Up Facility.

Nutritional Growth Solutions (ASX – NGS) has locked in a $2 million capital raise through a share placement aimed at fueling sales, inventory, and growth initiatives, pending shareholder approval.

Holista Colltech reported improved cash flow management and robust growth in its dietary supplements division for 3QFY25, while navigating ongoing legal challenges with ProImmune.

Nutritional Growth Solutions reported a 13% revenue increase in Q3 FY25, driven by expanded US retail distribution and inventory replenishment. The company raised AU$760k to support growth but faces a tight cash runway, banking on upcoming capital raises and retail momentum.

Holista Colltech reports a sharp 70% reduction in net loss and an 8.6% revenue rise, driven by strong supplements sales and a landmark collagen partnership with Regenerex Pharma.